65 i b, drugs, pharmaceuticals,&hematology related products, FSS contract award

Ended Awarded Last action

Contract number
36F79719D0245
Awardee
Awarding agency
Task orders
1

Award facts

Opportunity
  • 65IB Solicitation number
Last date to order 100% complete
IDV ceiling
$111,172,590.00
Award type
Multiple award
Who can order
All agencies
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Negotiated Proposal / Quote
Pricing
Fixed Price with Economic Price Adjustment

Award details come from SAM.gov/FPDS.

About this IDV

The VA Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule contract to Amag Pharmaceuticals, Inc. under FSS-61-IB (Pharmaceuticals and Drugs) effective September 1, 2019, with a ceiling value of $111,172,590 and an ultimate completion date of August 31, 2026. This multiple-award schedule contract enables the VA to place orders for bremelanotide (Vyleesi) and related pharmaceuticals and drugs across its nationwide healthcare network without running separate competitions. Performance takes place nationwide through VA medical centers and clinics. The schedule carries no set-aside designation.

Under this master schedule, the VA Veterans Health Administration Veterans Integrated Service Network 20 issued a $633 firm-fixed-price delivery order to Amag on October 30, 2020, for bremelanotide (Vyleesi), a prescription medication used to treat hypoactive sexual desire disorder in premenopausal women. That order was completed by June 10, 2021, with performance in Waltham, Massachusetts.

Amag Pharmaceuticals, Inc. is a specialty pharmaceutical manufacturer classified as foreign-owned and registered in SAM.gov since 2009. The company specializes in therapeutic solutions for life-threatening conditions and chronic illnesses. Under the parent FSS-61-IB schedule, Amag also held a single-award Blanket Purchase Agreement valued at $2,250,000 with a base year plus four option years, awarded May 8, 2020, and ultimately cancelled when the parent schedule changed distribution of the product.

Task orders

Task order Ordering agency Obligated Awarded
Bremelanotide (vyleesi) 36C26021F0070 Veterans Integrated Service Network 20 (VHA) $634

IDV awards

IDV Agency Ceiling Awarded
36E79720A0010 BPA for vyleesi (base year with four one year option periods) National Acquisition Center (VA) $2,250,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00025 · Deletion and contract cancellation $0
Supplemental Agreement for work within scope P00024 · Public law pricing update $0
Other Administrative Action P00023 · Not applicable $0
Supplemental Agreement for work within scope P00022 · Deletions $0
Supplemental Agreement for work within scope P00021 · Temporary contract extension $0
Other Administrative Action P00020 · Sales POC $0
Supplemental Agreement for work within scope P00019 · Public law update 2025 $0
Supplemental Agreement for work within scope P00018 · Temporary contract extension $0
Other Administrative Action P00017 · Admin change $0
Supplemental Agreement for work within scope P00016 · 2024 public law pricing update $0
Other Administrative Action P00015 · Admin changes and sigauth $0
Supplemental Agreement for work within scope P00014 · Public law 2023 update $0
Supplemental Agreement for work within scope P00013 · Public law 2022 update $0
Supplemental Agreement for work within scope P00012 · Vylessi deletion $0
Other Administrative Action P00011 · POC change $0
Supplemental Agreement for work within scope P00010 · 2021 PL $0
Supplemental Agreement for work within scope P00009 · Deletion- intrarosa-sold to millicent pharma $0
Other Administrative Action P00008 · Speciality distributor -DMS added $0
Supplemental Agreement for work within scope P00007 · Temp to permanent for vyleesi $0
Supplemental Agreement for work within scope P00006 · TC change $0
Supplemental Agreement for work within scope P00005 · PL2020 $0
Supplemental Agreement for work within scope P00004 · Temporary federal ceiling price $0
Supplemental Agreement for work within scope P00003 · POC change $0
Supplemental Agreement for work within scope P00002 · Provisioanal addition -vyleesi $0
Other Administrative Action P00001 · POC change $0
Original award $0
Show all 26

Quick answers

Who was awarded contract 36F79719D0245?

36F79719D0245 was awarded to Amag Pharmaceuticals, Inc. by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 1, 2019.

How much is contract 36F79719D0245 worth?

36F79719D0245's own ceiling is $111,172,590.

How many orders have been placed under contract 36F79719D0245?

1 order has been placed under 36F79719D0245, the latest on October 30, 2020.

Who can order from contract 36F79719D0245?

36F79719D0245 is a multiple award federal supply schedule. All agencies can place orders on it.

Is contract 36F79719D0245 part of a contract vehicle?

Yes. 36F79719D0245 is part of Pharmaceuticals and Drugs (FSS-61-IB).

Was contract 36F79719D0245 competed?

The extent of competition for 36F79719D0245 was full and open competition.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV